Cost-effectiveness of Sacubitril/Valsartan in acute and chronic heart failure with reduced ejection fraction: from randomized controlled trials to real-world evidence

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 7 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by